DNTH
Price
$19.50
Change
+$0.52 (+2.74%)
Updated
Apr 17 closing price
Capitalization
626.46M
IMVT
Price
$15.15
Change
+$0.31 (+2.09%)
Updated
Apr 17 closing price
Capitalization
2.57B
39 days until earnings call
Ad is loading...

DNTH vs IMVT

Header iconDNTH vs IMVT Comparison
Open Charts DNTH vs IMVTBanner chart's image
Dianthus Therapeutics
Price$19.50
Change+$0.52 (+2.74%)
Volume$180.94K
Capitalization626.46M
Immunovant
Price$15.15
Change+$0.31 (+2.09%)
Volume$1.04M
Capitalization2.57B
DNTH vs IMVT Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. IMVT commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and IMVT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (DNTH: $19.50 vs. IMVT: $15.15)
Brand notoriety: DNTH and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 49% vs. IMVT: 58%
Market capitalization -- DNTH: $626.46M vs. IMVT: $2.57B
DNTH [@Biotechnology] is valued at $626.46M. IMVT’s [@Biotechnology] market capitalization is $2.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while IMVT’s TA Score has 5 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 5 bearish.
  • IMVT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а +25.00% price change this week, while IMVT (@Biotechnology) price change was +2.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 09, 2023.

IMVT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($2.57B) has a higher market cap than DNTH($626M). DNTH YTD gains are higher at: -10.550 vs. IMVT (-38.837). DNTH has higher annual earnings (EBITDA): -101.45M vs. IMVT (-404.87M). IMVT has more cash in the bank: 375M vs. DNTH (275M). IMVT has less debt than DNTH: IMVT (23K) vs DNTH (1.49M). DNTH has higher revenues than IMVT: DNTH (6.24M) vs IMVT (0).
DNTHIMVTDNTH / IMVT
Capitalization626M2.57B24%
EBITDA-101.45M-404.87M25%
Gain YTD-10.550-38.83727%
P/E Ratio3.24N/A-
Revenue6.24M0-
Total Cash275M375M73%
Total Debt1.49M23K6,483%
FUNDAMENTALS RATINGS
DNTH vs IMVT: Fundamental Ratings
DNTH
IMVT
OUTLOOK RATING
1..100
6172
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
4686
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
7891
P/E GROWTH RATING
1..100
57100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DNTH's Valuation (56) in the null industry is in the same range as IMVT (63). This means that DNTH’s stock grew similarly to IMVT’s over the last 12 months.

DNTH's Profit vs Risk Rating (46) in the null industry is somewhat better than the same rating for IMVT (86). This means that DNTH’s stock grew somewhat faster than IMVT’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as IMVT (98). This means that DNTH’s stock grew similarly to IMVT’s over the last 12 months.

DNTH's Price Growth Rating (78) in the null industry is in the same range as IMVT (91). This means that DNTH’s stock grew similarly to IMVT’s over the last 12 months.

DNTH's P/E Growth Rating (57) in the null industry is somewhat better than the same rating for IMVT (100). This means that DNTH’s stock grew somewhat faster than IMVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHIMVT
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+2.74%
IMNM - DNTH
46%
Loosely correlated
+10.32%
IMVT - DNTH
45%
Loosely correlated
+2.09%
COGT - DNTH
44%
Loosely correlated
+2.34%
RNA - DNTH
44%
Loosely correlated
+3.49%
CRNX - DNTH
44%
Loosely correlated
+2.84%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+2.09%
ROIV - IMVT
60%
Loosely correlated
+1.30%
RCKT - IMVT
50%
Loosely correlated
+2.93%
DNLI - IMVT
47%
Loosely correlated
+1.51%
XENE - IMVT
45%
Loosely correlated
+3.94%
IDYA - IMVT
45%
Loosely correlated
+5.56%
More